Clinical trial
Antioxidant Therapy in RYR1-Related Congenital Myopathy
NCT02362425 is registered in ClinicalTrials.gov with National Institute of Nursing Research (NINR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antioxidant Therapy in RYR1-Related Congenital Myopathy
- Lead sponsor
- National Institute of Nursing Research (NINR)
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 12, 2015
- Completion date
- May 30, 2018
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuromuscular disease